Assessment of Capecitabine and Bevacizumab With or Without Atezolizumab for the Treatment of Refractory Metastatic Colorectal CancerNiharika B. Mettu, Tanios Bekaii‐Saab|JAMA Network Open|2022Cited by 121
Abstract B048: NUC-3373 in combination with irinotecan (NUFIRI) or oxaliplatin (NUFOX) and bevacizumab for second-line treatment of patients with advanced colorectal cancer (NuTide:302)Khurum Khan, T.R. Jeffry Evans, Uma Mukherjee et al.|Molecular Cancer Therapeutics|2023Cited by 1
Functional genomic screens and identification of signaling pathways in oxaliplatin-resistance in colorectal cancer.Niharika B. Mettu, Shiaowen David Hsu, Koya Osada et al.|Journal of Clinical Oncology|2014Cited by 0